🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the safety and efficacy of orelabrutinib (O) in...
Status
Recruiting
Location
Changzhou Second People's Hospital
Start Date
2026-07-15
Trial ID
NCT07719556
Treatments Being Tested
This study compares the titration pressures achieved through two auto-titra...
Status
Completed
Location
Hospital Universitario Araba
Start Date
2018-04-01
Trial ID
NCT03734341
Treatments Being Tested
Cushing's disease is a rare serious condition that is caused by an adrenoco...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2004-08-13
Trial ID
NCT00171951
Treatments Being Tested
This study is intended primarily to compare the effects of two Class II cor...
Status
Enrolling By Invitation
Location
University of Baghdad, College of Dentistry
Start Date
2025-05-20
Trial ID
NCT06976749
Treatments Being Tested
This was an open-label, non-randomized, multicenter, Phase 2 study evaluati...
Status
Completed
Location
Moores Cancer Center at UC San Diego /ID# 128535
Start Date
2014-09-10
Trial ID
NCT02141282
Treatments Being Tested
The aim of this study is to evaluate if standard chemoimmunotherapy (FCR, B...
Status
Completed
Location
Medizinische Universitaet Wien
Start Date
2016-12-13
Trial ID
NCT02950051
Treatments Being Tested
This study is a multicenter, open-label, uncontrolled, phase II trial aimed...
Status
Active Not Recruiting
Location
Az. Ss.Antonio E Biagio E C.Arrigo - Osp.Civile Ss.Antonio E Biagio
Start Date
2019-10-04
Trial ID
NCT04082897
Treatments Being Tested
This is a French multicenter open label non-randomized Phase II trial evalu...
Status
Not Yet Recruiting
Location
AMIENS - CH Amiens Picardie Site Sud
Start Date
2025-12-01
Trial ID
NCT06547866
Treatments Being Tested
CC-90011-AML-002 is a Phase 1/2, open-label, multicenter study to assess th...
Status
Terminated
Location
Local Institution - 110
Start Date
2021-10-14
Trial ID
NCT04748848
Treatments Being Tested
The purpose of the study was to find out if the new drug sabatolimab when g...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2021-05-31
Trial ID
NCT04812548
Treatments Being Tested